# VXM01 Phase I Pilot Study in Patients With Operable Recurrence of a Glioblastoma

> **NCT02718443** · PHASE1 · COMPLETED · sponsor: **Vaximm GmbH** · enrollment: 14 (actual)

## Conditions studied

- Glioblastoma

## Interventions

- **DRUG:** VXM01

## Key facts

- **NCT ID:** NCT02718443
- **Lead sponsor:** Vaximm GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-05
- **Primary completion:** 2017-08
- **Final completion:** 2018-07
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2018-10-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02718443

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02718443, "VXM01 Phase I Pilot Study in Patients With Operable Recurrence of a Glioblastoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02718443. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*